Company Overview of OsteoGeneX Inc.
OsteoGeneX Inc. engages in the research and development of small molecule therapeutics focusing on sclerostin and Wnt modulators in the United States. It focuses on developing drug candidates for the treatment of osteoporosis, synthetic bone grafts, and cancer. The company was founded in 2006 and is based in Kansas City, Kansas.
3800 Cambridge Street
Kansas City, KS 66160
Founded in 2006
Key Executives for OsteoGeneX Inc.
Similar Private Companies By Industry
|Stason Pharmaceuticals, Inc.||United States|
|Galleon Pharmaceuticals, Inc.||United States|
|Akorn (New Jersey), Inc.||United States|
|Abeille Pharmaceuticals, Inc.||United States|
|Applied Pharma Research USA, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact OsteoGeneX Inc., please visit www.osteogenex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.